{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T07:19:05Z","timestamp":1794467945008,"version":"4.9.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T00:00:00Z","timestamp":1613952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T00:00:00Z","timestamp":1613952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1038\/s41417-021-00302-y","type":"journal-article","created":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T13:05:59Z","timestamp":1613999159000},"page":"225-240","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["DNA-double strand breaks enhance the expression of major histocompatibility complex class II through the ATM-NF-\u03ba\u0392-IRF1-CIITA pathway"],"prefix":"10.1038","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8941-161X","authenticated-orcid":false,"given":"Tsukasa","family":"Oda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruri","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7943-9176","authenticated-orcid":false,"given":"Tetsuhiro","family":"Kasamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanami","family":"Gotoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5524-7455","authenticated-orcid":false,"given":"Takayuki","family":"Saitoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3753-9862","authenticated-orcid":false,"given":"Hiroshi","family":"Handa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1766-4615","authenticated-orcid":false,"given":"Hirokazu","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2074-9310","authenticated-orcid":false,"given":"Takayuki","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,22]]},"reference":[{"issue":"Suppl","key":"302_CR1","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/S0092-8674(02)00696-7","volume":"109","author":"JP Ting","year":"2002","unstructured":"Ting JP, Trowsdale J. Genetic control of MHC class II expression. Cell. 2002;109(Suppl):S21\u201333.","journal-title":"Cell"},{"key":"302_CR2","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1002\/eji.200424964","volume":"34","author":"S LeibundGut-Landmann","year":"2004","unstructured":"LeibundGut-Landmann S, Waldburger JM, Krawczyk M, Otten LA, Suter T, Fontana A, et al. Mini-review: specificity and expression of CIITA, the master regulator of MHC class II genes. Eur J Immunol. 2004;34:1513\u201325.","journal-title":"Eur J Immunol"},{"key":"302_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0952-7915(02)00015-8","volume":"15","author":"JM Boss","year":"2003","unstructured":"Boss JM, Jensen PE. Transcriptional regulation of the MHC class II antigen presentation pathway. Curr Opin Immunol. 2003;15:105\u201311.","journal-title":"Curr Opin Immunol"},{"key":"302_CR4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.it.2006.07.007","volume":"27","author":"KL Wright","year":"2006","unstructured":"Wright KL, Ting JP. Epigenetic regulation of MHC-II and CIITA genes. Trends Immunol. 2006;27:405\u201312.","journal-title":"Trends Immunol"},{"key":"302_CR5","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.cell.2017.01.002","volume":"168","author":"A Tubbs","year":"2017","unstructured":"Tubbs A, Nussenzweig A. Endogenous DNA damage as a source of genomic instability in cancer. Cell. 2017;168:644\u201356.","journal-title":"Cell"},{"key":"302_CR6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.molcel.2010.09.019","volume":"40","author":"A Ciccia","year":"2010","unstructured":"Ciccia A, Elledge SJ. The DNA damage response: making it safe to play with knives. Mol Cell. 2010;40:179\u2013204.","journal-title":"Mol Cell"},{"key":"302_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.dnarep.2015.12.009","volume":"39","author":"A Guleria","year":"2016","unstructured":"Guleria A, Chandna S. ATM kinase: Much more than a DNA damage responsive protein. DNA Repair. 2016;39:1\u201320.","journal-title":"DNA Repair"},{"key":"302_CR8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/nrc3916","volume":"15","author":"H Gaillard","year":"2015","unstructured":"Gaillard H, Garcia-Muse T, Aguilera A. Replication stress and cancer. Nat Rev Cancer. 2015;15:276\u201389.","journal-title":"Nat Rev Cancer"},{"key":"302_CR9","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1093\/nar\/gkv061","volume":"43","author":"V Turinetto","year":"2015","unstructured":"Turinetto V, Giachino C. Multiple facets of histone variant H2AX: a DNA double-strand-break marker with several biological functions. Nucleic Acids Res. 2015;43:2489\u201398.","journal-title":"Nucleic Acids Res"},{"key":"302_CR10","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.15252\/embr.201439245","volume":"15","author":"BG Childs","year":"2014","unstructured":"Childs BG, Baker DJ, Kirkland JL, Campisi J, van Deursen JM. Senescence and apoptosis: dueling or complementary cell fates? EMBO Rep. 2014;15:1139\u201353.","journal-title":"EMBO Rep"},{"key":"302_CR11","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1084\/jem.20180139","volume":"215","author":"T Li","year":"2018","unstructured":"Li T, Chen ZJ. The cGAS-cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer. J Exp Med. 2018;215:1287\u201399.","journal-title":"J Exp Med"},{"key":"302_CR12","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.chembiol.2013.04.007","volume":"20","author":"K Cheung-Ong","year":"2013","unstructured":"Cheung-Ong K, Giaever G, Nislow C. DNA-damaging agents in cancer chemotherapy: serendipity and chemical biology. Chem Biol. 2013;20:648\u201359.","journal-title":"Chem Biol"},{"key":"302_CR13","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.canlet.2014.12.039","volume":"358","author":"I Kareva","year":"2015","unstructured":"Kareva I, Waxman DJ, Lakka, Klement G. Metronomic chemotherapy: an attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance. Cancer Lett. 2015;358:100\u20136.","journal-title":"Cancer Lett"},{"key":"302_CR14","doi-asserted-by":"crossref","unstructured":"Oda T, Sekimoto T, Kurashima K, Fujimoto M, Nakai A, Yamashita T. Acute HSF1 depletion induces cellular senescence through the MDM2-p53-p21 pathway in human diploid fibroblasts. J Cell Sci. 2018;131:jcs210724.","DOI":"10.1242\/jcs.210724"},{"key":"302_CR15","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nrc3257","volume":"12","author":"GJ Morgan","year":"2012","unstructured":"Morgan GJ, Walker BA, Davies FE. The genetic architecture of multiple myeloma. Nat Rev Cancer. 2012;12:335\u201348.","journal-title":"Nat Rev Cancer"},{"key":"302_CR16","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.cell.2012.08.005","volume":"150","author":"F Mattiroli","year":"2012","unstructured":"Mattiroli F, Vissers JH, van Dijk WJ, Ikpa P, Citterio E, Vermeulen W, et al. RNF168 ubiquitinates K13-15 on H2A\/H2AX to drive DNA damage signaling. Cell. 2012;150:1182\u201395.","journal-title":"Cell"},{"key":"302_CR17","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nrc3088","volume":"11","author":"AJ Deans","year":"2011","unstructured":"Deans AJ, West SC. DNA interstrand crosslink repair and cancer. Nat Rev Cancer. 2011;11:467\u201380.","journal-title":"Nat Rev Cancer"},{"key":"302_CR18","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.4161\/cbt.21093","volume":"13","author":"R Prevo","year":"2012","unstructured":"Prevo R, Fokas E, Reaper PM, Charlton PA, Pollard JR, McKenna WG, et al. The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy. Cancer Biol Ther. 2012;13:1072\u201381.","journal-title":"Cancer Biol Ther"},{"key":"302_CR19","first-page":"84","volume":"1845","author":"F Yang","year":"2014","unstructured":"Yang F, Teves SS, Kemp CJ, Henikoff S. Doxorubicin, DNA torsion, and chromatin dynamics. Biochim Biophys Acta. 2014;1845:84\u201389.","journal-title":"Biochim Biophys Acta"},{"key":"302_CR20","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/jrr\/rrx014","volume":"58","author":"H Zhou","year":"2017","unstructured":"Zhou H, Kawamura K, Yanagihara H, Kobayashi J, Zhang-Akiyama QM. NBS1 is regulated by two kind of mechanisms: ATM-dependent complex formation with MRE11 and RAD50, and cell cycle-dependent degradation of protein. J Radiat Res. 2017;58:487\u201394.","journal-title":"J Radiat Res"},{"key":"302_CR21","doi-asserted-by":"publisher","first-page":"872","DOI":"10.4161\/cbt.6.6.4088","volume":"6","author":"A Papageorgiou","year":"2007","unstructured":"Papageorgiou A, Dinney CP, McConkey DJ. Interferon-alpha induces TRAIL expression and cell death via an IRF-1-dependent mechanism in human bladder cancer cells. Cancer Biol Ther. 2007;6:872\u20139.","journal-title":"Cancer Biol Ther"},{"key":"302_CR22","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.immuni.2013.01.012","volume":"38","author":"D Venkatesh","year":"2013","unstructured":"Venkatesh D, Ernandez T, Rosetti F, Batal I, Cullere X, Luscinskas FW, et al. Endothelial TNF receptor 2 induces IRF1 transcription factor-dependent interferon-beta autocrine signaling to promote monocyte recruitment. Immunity. 2013;38:1025\u201337.","journal-title":"Immunity"},{"key":"302_CR23","doi-asserted-by":"publisher","first-page":"G991","DOI":"10.1152\/ajpgi.00231.2018","volume":"315","author":"JR Klune","year":"2018","unstructured":"Klune JR, Bartels C, Luo J, Yokota S, Du Q, Geller DA. IL-23 mediates murine liver transplantation ischemia-reperfusion injury via IFN-gamma\/IRF-1 pathway. Am J Physiol Gastrointest Liver Physiol. 2018;315:G991\u2013G1002.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"302_CR24","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/emm.2004.49","volume":"36","author":"SJ Yu","year":"2004","unstructured":"Yu SJ, Kim HS, Cho SW, Sohn J. IL-4 inhibits proliferation of renal carcinoma cells by increasing the expression of p21WAF1 and IRF-1. Exp Mol Med. 2004;36:372\u20139.","journal-title":"Exp Mol Med"},{"key":"302_CR25","doi-asserted-by":"publisher","first-page":"7256","DOI":"10.4049\/jimmunol.162.12.7256","volume":"162","author":"J Galon","year":"1999","unstructured":"Galon J, Sudarshan C, Ito S, Finbloom D, O\u2019Shea JJ. IL-12 induces IFN regulating factor-1 (IRF-1) gene expression in human NK and T cells. J Immunol. 1999;162:7256\u201362.","journal-title":"J Immunol"},{"key":"302_CR26","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1126\/science.1121513","volume":"311","author":"ZH Wu","year":"2006","unstructured":"Wu ZH, Shi Y, Tibbetts RS, Miyamoto S. Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli. Science. 2006;311:1141\u20136.","journal-title":"Science"},{"key":"302_CR27","doi-asserted-by":"publisher","first-page":"7776","DOI":"10.1038\/sj.onc.1205981","volume":"21","author":"J Pamment","year":"2002","unstructured":"Pamment J, Ramsay E, Kelleher M, Dornan D, Ball KL. Regulation of the IRF-1 tumour modifier during the response to genotoxic stress involves an ATM-dependent signalling pathway. Oncogene. 2002;21:7776\u201385.","journal-title":"Oncogene"},{"key":"302_CR28","doi-asserted-by":"publisher","first-page":"5336","DOI":"10.4049\/jimmunol.1100040","volume":"187","author":"S Brzostek-Racine","year":"2011","unstructured":"Brzostek-Racine S, Gordon C, Van Scoy S, Reich NC. The DNA damage response induces IFN. J Immunol. 2011;187:5336\u201345.","journal-title":"J Immunol"},{"key":"302_CR29","doi-asserted-by":"publisher","first-page":"21783","DOI":"10.1074\/jbc.M112.355495","volume":"287","author":"J Niu","year":"2012","unstructured":"Niu J, Shi Y, Tan G, Yang CH, Fan M, Pfeffer LM, et al. DNA damage induces NF-kappaB-dependent microRNA-21 up-regulation and promotes breast cancer cell invasion. J Biol Chem. 2012;287:21783\u201395.","journal-title":"J Biol Chem"},{"key":"302_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0876-3","volume":"9","author":"N Wang","year":"2018","unstructured":"Wang N, Liu W, Zheng Y, Wang S, Yang B, Li M, et al. CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-kappaB\/SOX4 signaling. Cell Death Dis. 2018;9:880.","journal-title":"Cell Death Dis"},{"key":"302_CR31","doi-asserted-by":"publisher","first-page":"36916","DOI":"10.1074\/jbc.M301598200","volume":"278","author":"H Sakurai","year":"2003","unstructured":"Sakurai H, Suzuki S, Kawasaki N, Nakano H, Okazaki T, Chino A, et al. Tumor necrosis factor-alpha-induced IKK phosphorylation of NF-kappaB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway. J Biol Chem. 2003;278:36916\u201323.","journal-title":"J Biol Chem"},{"key":"302_CR32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ccr.2007.07.004","volume":"12","author":"CM Annunziata","year":"2007","unstructured":"Annunziata CM, Davis RE, Demchenko Y, Bellamy W, Gabrea A, Zhan F, et al. Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell. 2007;12:115\u201330.","journal-title":"Cancer Cell"},{"key":"302_CR33","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.molcel.2018.07.034","volume":"71","author":"G Dunphy","year":"2018","unstructured":"Dunphy G, Flannery SM, Almine JF, Connolly DJ, Paulus C, Jonsson KL, et al. Non-canonical activation of the DNA sensing adaptor STING by ATM and IFI16 mediates NF-kappaB signaling after nuclear DNA damage. Mol Cell. 2018;71:745\u201360.e745.","journal-title":"Mol Cell"},{"key":"302_CR34","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.4049\/jimmunol.1700699","volume":"199","author":"R Fang","year":"2017","unstructured":"Fang R, Wang C, Jiang Q, Lv M, Gao P, Yu X, et al. NEMO-IKKbeta are essential for IRF3 and NF-kappaB activation in the cGAS-STING pathway. J Immunol. 2017;199:3222\u201333.","journal-title":"J Immunol"},{"key":"302_CR35","doi-asserted-by":"crossref","unstructured":"Kurashima K, Sekimoto T, Oda T, Kawabata T, Hanaoka F, Yamashita T. Pol\u03b7, a Y-family translesion synthesis polymerase, promotes cellular tolerance of Myc-induced replication stress. J Cell Sci. 2018;131:jcs212183.","DOI":"10.1242\/jcs.212183"},{"key":"302_CR36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nri3405","volume":"13","author":"L Chen","year":"2013","unstructured":"Chen L, Flies DB. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol. 2013;13:227\u201342.","journal-title":"Nat Rev Immunol"},{"key":"302_CR37","doi-asserted-by":"publisher","first-page":"5018","DOI":"10.4049\/jimmunol.1000079","volume":"184","author":"H Yoon","year":"2010","unstructured":"Yoon H, Boss JM. PU.1 binds to a distal regulatory element that is necessary for B cell-specific expression of CIITA. J Immunol. 2010;184:5018\u201328.","journal-title":"J Immunol"},{"key":"302_CR38","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.4049\/jimmunol.1103371","volume":"189","author":"HS Yoon","year":"2012","unstructured":"Yoon HS, Scharer CD, Majumder P, Davis CW, Butler R, Zinzow-Kramer W, et al. ZBTB32 is an early repressor of the CIITA and MHC class II gene expression during B cell differentiation to plasma cells. J Immunol. 2012;189:2393\u2013403.","journal-title":"J Immunol"},{"key":"302_CR39","first-page":"1500","volume":"14","author":"H Harada","year":"1994","unstructured":"Harada H, Takahashi E, Itoh S, Harada K, Hori TA, Taniguchi T. Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes: implications for a gene network in the interferon system. Mol Cell Biol. 1994;14:1500\u20139.","journal-title":"Mol Cell Biol"},{"key":"302_CR40","doi-asserted-by":"crossref","unstructured":"Martin OCB, Frisan T. Bacterial genotoxin-induced DNA damage and modulation of the host immune microenvironment. Toxins. 2020;12:63.","DOI":"10.3390\/toxins12020063"},{"key":"302_CR41","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/ijc.2910170504","volume":"17","author":"C Sundstrom","year":"1976","unstructured":"Sundstrom C, Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer. 1976;17:565\u201377.","journal-title":"Int J Cancer"},{"key":"302_CR42","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/ijc.2910260208","volume":"26","author":"S Tsuchiya","year":"1980","unstructured":"Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer. 1980;26:171\u20136.","journal-title":"Int J Cancer"},{"key":"302_CR43","first-page":"7955","volume":"50","author":"Y Morishita","year":"1990","unstructured":"Morishita Y, Kataoka T, Towatari M, Ito T, Inoue H, Ogura M, et al. Up-regulation of transferrin receptor gene expression by granulocyte colony-stimulating factor in human myeloid leukemia cells. Cancer Res. 1990;50:7955\u201361.","journal-title":"Cancer Res"},{"key":"302_CR44","first-page":"41","volume":"9","author":"GD Birnie","year":"1988","unstructured":"Birnie GD. The HL60 cell line: a model system for studying human myeloid cell differentiation. Br J Cancer Suppl. 1988;9:41\u201345.","journal-title":"Br J Cancer Suppl"},{"key":"302_CR45","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1055\/s-0038-1646396","volume":"66","author":"K Niiya","year":"1991","unstructured":"Niiya K, Takeuchi T, Kobayashi M, Miyoshi I, Hayashi T, Sakuragawa N. Dexamethasone and phorbol ester, but not cytokines, increase the production of plasminogen activator inhibitor type-2 in the PL-21 human promyelocytic leukemia cell line. Thromb Haemost. 1991;66:232\u20138.","journal-title":"Thromb Haemost"},{"key":"302_CR46","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.coi.2004.11.008","volume":"17","author":"E Zika","year":"2005","unstructured":"Zika E, Ting JP. Epigenetic control of MHC-II: interplay between CIITA and histone-modifying enzymes. Curr Opin Immunol. 2005;17:58\u201364.","journal-title":"Curr Opin Immunol"},{"key":"302_CR47","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.humimm.2008.07.001","volume":"69","author":"K Kondo","year":"2008","unstructured":"Kondo K, Okuma K, Tanaka R, Matsuzaki G, Ansari AA, Tanaka Y. Rapid induction of OX40 ligand on primary T cells activated under DNA-damaging conditions. Hum Immunol. 2008;69:533\u201342.","journal-title":"Hum Immunol"},{"key":"302_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01883-9","volume":"8","author":"H Sato","year":"2017","unstructured":"Sato H, Niimi A, Yasuhara T, Permata TBM, Hagiwara Y, Isono M, et al. DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells. Nat Commun. 2017;8:1751.","journal-title":"Nat Commun"},{"key":"302_CR49","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s00432-003-0492-0","volume":"129","author":"S Ohtsukasa","year":"2003","unstructured":"Ohtsukasa S, Okabe S, Yamashita H, Iwai T, Sugihara K. Increased expression of CEA and MHC class I in colorectal cancer cell lines exposed to chemotherapy drugs. J Cancer Res Clin Oncol. 2003;129:719\u201326.","journal-title":"J Cancer Res Clin Oncol"},{"key":"302_CR50","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nri3818","volume":"15","author":"PA Roche","year":"2015","unstructured":"Roche PA, Furuta K. The ins and outs of MHC class II-mediated antigen processing and presentation. Nat Rev Immunol. 2015;15:203\u201316.","journal-title":"Nat Rev Immunol"},{"key":"302_CR51","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00251-017-0986-6","volume":"69","author":"A Kelly","year":"2017","unstructured":"Kelly A, Trowsdale J. Introduction: MHC\/KIR and governance of specificity. Immunogenetics. 2017;69:481\u20138.","journal-title":"Immunogenetics"},{"key":"302_CR52","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90061-6","volume":"82","author":"LK Denzin","year":"1995","unstructured":"Denzin LK, Cresswell P. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell. 1995;82:155\u201365.","journal-title":"Cell"},{"key":"302_CR53","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.celrep.2018.06.054","volume":"24","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Harrison DL, Song Y, Ji J, Huang J, Hui E. Antigen-presenting cell-intrinsic PD-1 neutralizes PD-L1 in cis to attenuate PD-1 signaling in T cells. Cell Rep. 2018;24:379\u201390.e376.","journal-title":"Cell Rep"},{"key":"302_CR54","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00262-012-1343-0","volume":"62","author":"M Tongu","year":"2013","unstructured":"Tongu M, Harashima N, Monma H, Inao T, Yamada T, Kawauchi H, et al. Metronomic chemotherapy with low-dose cyclophosphamide plus gemcitabine can induce anti-tumor T cell immunity in vivo. Cancer Immunol Immunother. 2013;62:383\u201391.","journal-title":"Cancer Immunol Immunother"},{"key":"302_CR55","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrclinonc.2010.82","volume":"7","author":"E Pasquier","year":"2010","unstructured":"Pasquier E, Kavallaris M, Andre N. Metronomic chemotherapy: new rationale for new directions. Nat Rev Clin Oncol. 2010;7:455\u201365.","journal-title":"Nat Rev Clin Oncol"},{"key":"302_CR56","doi-asserted-by":"publisher","first-page":"5483791","DOI":"10.1155\/2019\/5483791","volume":"2019","author":"C Simsek","year":"2019","unstructured":"Simsek C, Esin E, Yalcin S. Metronomic chemotherapy: a systematic review of the literature and clinical experience. J Oncol. 2019;2019:5483791.","journal-title":"J Oncol"},{"key":"302_CR57","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nrc.2018.6","volume":"18","author":"W Ngwa","year":"2018","unstructured":"Ngwa W, Irabor OC, Schoenfeld JD, Hesser J, Demaria S, Formenti SC. Using immunotherapy to boost the abscopal effect. Nat Rev Cancer. 2018;18:313\u201322.","journal-title":"Nat Rev Cancer"},{"key":"302_CR58","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.it.2018.06.001","volume":"39","author":"ME Rodriguez-Ruiz","year":"2018","unstructured":"Rodriguez-Ruiz ME, Vanpouille-Box C, Melero I, Formenti SC, Demaria S. Immunological mechanisms responsible for radiation-induced abscopal effect. Trends Immunol. 2018;39:644\u201355.","journal-title":"Trends Immunol"},{"key":"302_CR59","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.1182\/blood-2006-10-051318","volume":"109","author":"A Perez-Diez","year":"2007","unstructured":"Perez-Diez A, Joncker NT, Choi K, Chan WF, Anderson CC, Lantz O, et al. CD4 cells can be more efficient at tumor rejection than CD8 cells. Blood. 2007;109:5346\u201354.","journal-title":"Blood"},{"key":"302_CR60","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41586-019-1671-8","volume":"574","author":"E Alspach","year":"2019","unstructured":"Alspach E, Lussier DM, Miceli AP, Kizhvatov I, DuPage M, Luoma AM, et al. MHC-II neoantigens shape tumour immunity and response to immunotherapy. Nature. 2019;574:696\u2013701.","journal-title":"Nature"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-021-00302-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-021-00302-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-021-00302-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T13:04:28Z","timestamp":1674997468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-021-00302-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,22]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["302"],"URL":"https:\/\/doi.org\/10.1038\/s41417-021-00302-y","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,22]]},"assertion":[{"value":"8 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}